Rx (Prescription Medicine)
USD $ 45.00
Sutent 12.5mg Capsule 是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分 sunitinib 是一种酪氨酸激酶抑制剂，通过阻断癌细胞生长与分裂所需的信号传导起作用。通过抑制这些信号，Sutent 有助于减缓或停止肿瘤的生长，同时还能抑制肿瘤生存所需的新血管形成。
Sutent 主要适应症包括：转移性肾细胞癌（肾癌）、胃肠道间质瘤（GIST）（在疾病进展或对先前治疗耐受性不佳之后）、以及进展性胰腺神经内分泌肿瘤（pNET）患者的治疗。
Sutent 的典型用法和剂量应严格遵医嘱。通常每日口服一次，可与食物同服或空腹服用。如需根据个体反应和耐受性进行剂量调整，请务必遵医嘱。
Sutent 常见的不良反应包括疲劳、腹泻、恶心、呕吐、高血压、皮疹以及皮肤和毛发的颜色改变。更严重的不良反应也可能发生，如出现任何异常症状，请立即向医生报告。开始治疗前，务必与肿瘤科医生充分讨论潜在的风险与收益。
Sutent 12.5mg Capsules 应储存在室温，远离潮湿和热源。请放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Pack Quantity | |
| Strength |
其他品牌的 Sunitinib 12.5 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
